Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Immunopathol Pharmacol ; 35: 20587384211008291, 2021.
Article in English | MEDLINE | ID: mdl-33787390

ABSTRACT

Probiotics are microorganisms that confer health benefits to host. Well-known examples include Bifidobacterium and Lactobacillus species. In recent years, interest in promoting our health with probiotics has grown as life expectancy and health awareness has increased. However, some concerns for safety and stability exist for these live organisms. Thus, "postbiotics" and "paraprobiotics," non-viable heat-killed microbial cells or cell fractions that retain health benefits, are increasingly favored. Unfortunately, little information on clinical efficacy and mechanisms of action is available compared with many available probiotics. Lacticaseibacillus (previous name Lactobacillus) paracasei MCC1849 is a commonly used lactic acid bacterial strain in Japan that displays immuno-modulatory effects in humans in non-viable heat-killed form. This review discusses health benefits of heat-killed L. paracasei MCC1849 immune modulation and offers a theoretical basis for its mechanisms of action. We also discuss the feasibility of using heat-killed probiotics for application in food products.


Subject(s)
Immunologic Factors , Lacticaseibacillus paracasei , Probiotics , Animals , Food Microbiology , Hot Temperature , Humans , Immunomodulation
2.
Biosci Biotechnol Biochem ; 83(7): 1239-1247, 2019 Jul.
Article in English | MEDLINE | ID: mdl-30898081

ABSTRACT

The gut microbiota is involved in the pathogenesis of stress-related disorders. Probiotics can benefit the central nervous system via the microbiota-gut-brain axis, which raises the possibility that probiotics are effective in managing depression. In the present study, we examined the effects of heat-killed Lactobacillus helveticus strain MCC1848 in subchronic and mild social defeat stress (sCSDS) model mice (a widely used animal model of depression). MCC1848 supplementation significantly enhanced the interaction time in the social interaction test and sucrose preference ratio in the sucrose preference test, suggesting that MCC1848 improved anxiety- or depressive-like behaviors in sCSDS mice. The gene expression profile analysis of the nucleus accumbens, which plays an important role in stress resilience, indicated that MCC1848 ameliorated sCSDS-induced gene expression alterations in signal transduction or nervous system development. These findings suggest that MCC1848 supplementation is useful as a preventive strategy for chronic-stress-induced depression.


Subject(s)
Anxiety/prevention & control , Depression/prevention & control , Hot Temperature , Lactobacillus helveticus/physiology , Stress, Psychological , Animals , Behavior, Animal/drug effects , Gastrointestinal Microbiome/drug effects , Gene Expression Profiling , Male , Mice , Mice, Inbred C57BL , Mice, Inbred ICR , Probiotics/pharmacology
3.
PLoS Genet ; 12(1): e1005679, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26741492

ABSTRACT

Mitochondrial disorders have the highest incidence among congenital metabolic disorders characterized by biochemical respiratory chain complex deficiencies. It occurs at a rate of 1 in 5,000 births, and has phenotypic and genetic heterogeneity. Mutations in about 1,500 nuclear encoded mitochondrial proteins may cause mitochondrial dysfunction of energy production and mitochondrial disorders. More than 250 genes that cause mitochondrial disorders have been reported to date. However exact genetic diagnosis for patients still remained largely unknown. To reveal this heterogeneity, we performed comprehensive genomic analyses for 142 patients with childhood-onset mitochondrial respiratory chain complex deficiencies. The approach includes whole mtDNA and exome analyses using high-throughput sequencing, and chromosomal aberration analyses using high-density oligonucleotide arrays. We identified 37 novel mutations in known mitochondrial disease genes and 3 mitochondria-related genes (MRPS23, QRSL1, and PNPLA4) as novel causative genes. We also identified 2 genes known to cause monogenic diseases (MECP2 and TNNI3) and 3 chromosomal aberrations (6q24.3-q25.1, 17p12, and 22q11.21) as causes in this cohort. Our approaches enhance the ability to identify pathogenic gene mutations in patients with biochemically defined mitochondrial respiratory chain complex deficiencies in clinical settings. They also underscore clinical and genetic heterogeneity and will improve patient care of this complex disorder.


Subject(s)
Exome/genetics , Genetic Heterogeneity , Mitochondria/genetics , Mitochondrial Diseases/genetics , Adolescent , Child , Child, Preschool , Chromosome Aberrations , DNA, Mitochondrial/genetics , Female , Fibroblasts , High-Throughput Nucleotide Sequencing , Humans , INDEL Mutation/genetics , Infant , Infant, Newborn , Male , Mitochondria/pathology , Mitochondrial Diseases/diagnosis , Mitochondrial Diseases/pathology , Polymorphism, Single Nucleotide/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...